Vyndaqel® Premier médicament dans le traitement de la...

Vyndaqel® Premier médicament dans le traitement de la cardiomyopathie amyloïde à transthyrétine

How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
59
Journal:
Actualités Pharmaceutiques
DOI:
10.1016/S0515-3700(20)30261-5
Date:
June, 2020
File:
PDF, 157 KB
2020
Conversion to is in progress
Conversion to is failed